Notice of Intent to Publish a Funding Opportunity Announcement for Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
ID: 358911Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358911
Timeline
    Description

    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Liver Cirrhosis Network: Scientific and Data Coordination Center, aimed at soliciting applications for research on liver cirrhosis. This initiative seeks to complete enrollment in two ongoing studies: the Liver Cirrhosis Network Longitudinal Cohort Study and the RESCU clinical trial, which evaluates the efficacy and safety of rosuvastatin for cirrhosis. The selected cooperative agreement will provide essential clinical studies management and biostatistical assistance for data analyses and dissemination of findings. Interested small businesses are encouraged to prepare for application submission, with an estimated total program funding of $1,835,051 and a projected award date of July 1, 2026. For further inquiries, potential applicants may contact Dr. Edward Doo at dooe@niddk.nih.gov or by phone at 301-451-4524.

    Point(s) of Contact
    Edward Doo, MD
    (301) 451-4524
    dooe@niddk.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required). This initiative aims to solicit applications for research focused on liver cirrhosis, specifically to complete enrollment in ongoing studies, including the Liver Cirrhosis Network Longitudinal Cohort Study and the RESCU clinical trial. The program is significant for advancing understanding and treatment of liver diseases, with an estimated total funding of $3,302,147 and an award ceiling of $330,214, anticipating approximately 10 awards. Interested applicants, particularly small businesses with expertise in liver disease research, are encouraged to prepare for application submission, with the estimated synopsis post date on July 11, 2025, and a closing date of August 15, 2025. For further inquiries, contact Edward Doo, MD, at dooe@niddk.nih.gov or call 301-451-4524.
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to solicit applications for collaborative, multi-site research focused on advancing the diagnosis, management, and treatment of rare diseases, with an emphasis on addressing unmet clinical trial readiness needs. The funding, estimated at $1 million, will support specialized centers through cooperative agreements, with the NOFO expected to be published in winter 2024 and applications due in summer 2024. Interested applicants should prepare to develop meaningful collaborations, as the estimated award date is set for July 1, 2025.
    National Alzheimer’s Coordinating Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the establishment of a National Alzheimer's Coordinating Center (NACC) under a cooperative agreement. The NACC aims to serve as a national data resource for Alzheimer's disease and related dementias (AD/ADRD) research, facilitating data collection from Alzheimer’s Disease Research Centers (ADRCs) and enhancing communication within the ADRC program. This initiative is crucial for advancing research in the field of aging and dementia, providing a centralized hub for collaboration and data sharing. Interested small businesses are encouraged to prepare for the application process, with the estimated synopsis posting date on August 15, 2025, and the anticipated award date set for July 15, 2026. For further inquiries, potential applicants can contact Dr. Cerise Elliott at elliottce@nih.gov or by phone at 301-496-9350.
    Notice of Intent to Publish the re-issuance of the Notice of Funding Opportunity (NOFO) Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to re-issue the Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) under the Rare Diseases Clinical Research Network (RDCRN), aimed at enhancing research in the diagnosis, management, and treatment of rare diseases. Each RDCRC is required to focus on at least three rare diseases and propose two to four clinical research projects, including one longitudinal study, emphasizing a collaborative, multi-site approach to address significant clinical trial readiness gaps. This initiative reflects the government's commitment to advancing public health through innovative methodologies and stakeholder engagement in the rare disease domain, with applications expected to be due in June and fall of 2025. Interested applicants can reach out to Dr. Tiina K. Urv at 301-827-2746 or via email at urvtiin@mail.nih.gov for further information.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the NCI Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program will support seven awards with an estimated total funding of $60 million, and applications are open to small businesses. Interested applicants should note that the synopsis is expected to be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and the anticipated award date is August 1, 2026. For further inquiries, contact Brandy Heckman-Stoddard, Ph.D., M.P.H., at 240-276-7048 or via email at heckmanbm@mail.nih.gov.
    Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Interventions to Address Disparities in Liver Diseases and Liver Cancer," aimed at supporting research interventions that target health disparities in liver diseases and liver cancer among marginalized populations in the United States. This initiative encourages researchers to propose multi-level and multi-domain approaches that address social determinants of health, with a focus on improving screening, treatment, and health outcomes for affected groups, including racial and ethnic minorities and individuals with lower socioeconomic status. The grant has no specific budget limit and allows for a maximum project period of five years, with applications accepted starting September 5, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers, aimed at expanding an international cardiac surgery research platform. This initiative will focus on integrating various areas of research, including interventional cardiology, peri-operative care, dissemination and implementation science, circadian medicine, and mechanistic science, to enhance the health outcomes of adults with cardiovascular disease and related neurologic complications. The platform will also serve as a training ground for future clinical trialists and implementation researchers, fostering collaboration among academia, small businesses, and other stakeholders. While applications are not currently being solicited, interested parties are encouraged to prepare for future submissions, with the estimated synopsis post date set for February 2, 2026, and the estimated project start date anticipated for January 1, 2027. For further inquiries, potential applicants can contact Dr. Kathleen Fenton at kathleen.fenton@nih.gov or by phone at 301-221-7865.
    Notice of Intent to Publish a Funding Opportunity Announcement for Continuation of the NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the continuation of the NIDDK Hematology Central Coordinating Center (HCC) under a cooperative agreement. The HCC will collaborate with up to five Cooperative Centers of Excellence in Hematology (CCEH) to provide administrative support, develop communication strategies, and implement educational programs aimed at enhancing research in nonmalignant hematology. This initiative is crucial for fostering a national multidisciplinary research effort to study hematopoiesis and address nonmalignant hematologic diseases. The estimated total program funding is $1 million, with a single award anticipated, and the NOFO is expected to be published in December 2024, with applications due by March 2025. For further details, potential applicants should prepare to submit their proposals in alignment with the requirements outlined in the forthcoming NOFO.
    Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking applications for a Data Coordinating Center (DCC) to support multi-site investigator-initiated clinical trials through a cooperative agreement. The DCC will be responsible for project coordination, administration, data management, and biostatistical support for trials that may involve various therapeutic, behavioral, and prevention strategies relevant to the NHLBI's research mission. This opportunity is crucial for advancing clinical research and ensuring effective collaboration among investigators. Interested small businesses should prepare to submit their applications alongside a collaborating Clinical Coordinating Center (CCC) application by the due date, with the estimated award date set for May 1, 2026. For further inquiries, potential applicants can contact Dr. Yves Rosenberg at rosenbey@nhlbi.nih.gov or by phone at 301-435-0550.
    Forecast for The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the NINDS Human Biospecimen and Data Repository, aimed at advancing research in neurological disorders. This initiative will establish a repository to maintain and expand a collection of biospecimens, which will be made available to qualified academic and industry researchers to support basic, translational, and clinical research efforts. The total estimated funding for this program is $1,950,000, with one award anticipated, and interested applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on August 25, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Price at rebecca.price@nih.gov or by phone at 301-827-3587.